
[ Mon, Jun 12th 2023 ]: WOPRAI
[ Mon, Jun 12th 2023 ]: WOPRAI
[ Mon, Jun 12th 2023 ]: WOPRAI
[ Mon, Jun 12th 2023 ]: WOPRAI
[ Mon, Jun 12th 2023 ]: WOPRAI
[ Mon, Jun 12th 2023 ]: WOPRAI
[ Mon, Jun 12th 2023 ]: WOPRAI
[ Mon, Jun 12th 2023 ]: WOPRAI
[ Mon, Jun 12th 2023 ]: WOPRAI
[ Mon, Jun 12th 2023 ]: WOPRAI
[ Mon, Jun 12th 2023 ]: WOPRAI
[ Mon, Jun 12th 2023 ]: WOPRAI
[ Mon, Jun 12th 2023 ]: WOPRAI
[ Mon, Jun 12th 2023 ]: WOPRAI
[ Mon, Jun 12th 2023 ]: WOPRAI
[ Mon, Jun 12th 2023 ]: WOPRAI
[ Mon, Jun 12th 2023 ]: WOPRAI
[ Mon, Jun 12th 2023 ]: WOPRAI
[ Mon, Jun 12th 2023 ]: WOPRAI
[ Mon, Jun 12th 2023 ]: WOPRAI
[ Mon, Jun 12th 2023 ]: WOPRAI
[ Mon, Jun 12th 2023 ]: WOPRAI
[ Mon, Jun 12th 2023 ]: WOPRAI
[ Mon, Jun 12th 2023 ]: WOPRAI
[ Mon, Jun 12th 2023 ]: WOPRAI
[ Mon, Jun 12th 2023 ]: WOPRAI
[ Mon, Jun 12th 2023 ]: WOPRAI
[ Mon, Jun 12th 2023 ]: WOPRAI
[ Mon, Jun 12th 2023 ]: WOPRAI
[ Mon, Jun 12th 2023 ]: WOPRAI
[ Mon, Jun 12th 2023 ]: WOPRAI
[ Mon, Jun 12th 2023 ]: WOPRAI
[ Mon, Jun 12th 2023 ]: WOPRAI
[ Mon, Jun 12th 2023 ]: WOPRAI
[ Mon, Jun 12th 2023 ]: WOPRAI
[ Mon, Jun 12th 2023 ]: WOPRAI
[ Mon, Jun 12th 2023 ]: WOPRAI
[ Mon, Jun 12th 2023 ]: WOPRAI
[ Mon, Jun 12th 2023 ]: WOPRAI
[ Mon, Jun 12th 2023 ]: WOPRAI
[ Mon, Jun 12th 2023 ]: WOPRAI
[ Mon, Jun 12th 2023 ]: WOPRAI
[ Mon, Jun 12th 2023 ]: WOPRAI
[ Mon, Jun 12th 2023 ]: WOPRAI
[ Mon, Jun 12th 2023 ]: WOPRAI
[ Mon, Jun 12th 2023 ]: WOPRAI
[ Mon, Jun 12th 2023 ]: WOPRAI
[ Mon, Jun 12th 2023 ]: WOPRAI
Matthew Biegler Maintained (APTO) at Buy with Increased Target to $50 on, Jun 12th, 2023


🞛 This publication is a summary or evaluation of another publication
Matthew Biegler of Oppenheimer, Maintained "Aptose Biosciences Inc." (APTO) at Buy with Increased Target from $9 to $50 on, Jun 12th, 2023.
Matthew has made no other calls on APTO in the last 4 months.
There are 3 other peers that have a rating on APTO. Out of the 3 peers that are also analyzing APTO, 0 agree with Matthew's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Matthew
- Edward Tenthoff of "Piper Sandler" Maintained at Buy with Decreased Target to $37 on, Wednesday, June 7th, 2023
- Gregory Renza of "RBC Capital" Maintained at Buy with Decreased Target to $40 on, Wednesday, June 7th, 2023
- Carey Macrury of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $120 on, Monday, March 27th, 2023